Skip to main content
Top
Published in: Journal of General Internal Medicine 2/2019

01-02-2019 | Original Research

Predicting Fracture Risk in Younger Postmenopausal Women: Comparison of the Garvan and FRAX Risk Calculators in the Women’s Health Initiative Study

Authors: Carolyn J. Crandall, MD, MS, Joseph Larson, MS, Andrea LaCroix, PhD, Jane A. Cauley, DrPH, Meryl S. LeBoff, MD, Wenjun Li, PhD, Erin S. LeBlanc, MD, MPH, Beatrice J. Edwards, MD, MPH, JoAnn E. Manson, MD, DrPH, Kristine Ensrud, MD, MPH

Published in: Journal of General Internal Medicine | Issue 2/2019

Login to get access

Abstract

Background

Guidelines recommend fracture risk assessment in postmenopausal women aged 50–64, but the optimal method is unknown.

Objectives

To compare discrimination and calibration of the Fracture Risk Assessment Tool (FRAX) and Garvan fracture risk calculator for predicting fractures in postmenopausal women aged 50–64 at baseline.

Design

Prospective observational study.

Participants

Sixty-three thousand seven hundred twenty-three postmenopausal women aged 50–64 years participating in the Women’s Health Initiative Observational Study and Clinical Trials.

Main Measures

Incident hip fractures and major osteoporotic fractures (MOF) during 10-year follow-up. Calculated FRAX- and Garvan-predicted hip fracture and MOF fracture probabilities.

Key Results

The observed 10-year hip fracture probability was 0.3% for women aged 50–54 years (n = 14,768), 0.6% for women aged 55–59 years (n = 22,442), and 1.1% for women aged 60–64 years (n = 25,513). At sensitivity thresholds ≥ 80%, specificity of both tools for detecting incident hip fracture during 10 years of follow-up was low: Garvan 30.6% (95% confidence interval [CI] 30.3–31.0%) and FRAX 43.1% (95% CI 42.7–43.5%). At maximal area under the receiver operating characteristic curve (AUC(c), 0.58 for Garvan, 0.65 for FRAX), sensitivity was 16.0% (95% CI 12.7–19.4%) for Garvan and 59.2% (95% CI 54.7–63.7%) for FRAX. At AUC(c) values, sensitivity was lower in African American and Hispanic women than among white women and lower in women aged 50–54 than those 60–64 years old. Observed hip fracture probabilities were similar to FRAX-predicted probabilities but greater than Garvan-predicted probabilities. At AUC(c) values (0.56 for both tools), sensitivity for identifying MOF was also low (range 26.7–46.8%). At AUC(c) values (0.55 for both tools), sensitivity for identifying any clinical fracture ranged from 18.1 to 34.0%.

Conclusions

In postmenopausal women aged 50–64 years, the FRAX and Garvan fracture risk calculator discriminate poorly between women who do and do not experience fracture during 10-year follow-up. There is no useful threshold for either tool.
Appendix
Available only for authorised users
Literature
7.
go back to reference Jacobsen BK, Nilssen S, Heuch I, Kvale G. Reproductive factors and fatal hip fractures. A Norwegian prospective study of 63,000 women. J Epidemiol Community Health 1998;52(10):645–50.CrossRefPubMedCentralPubMed Jacobsen BK, Nilssen S, Heuch I, Kvale G. Reproductive factors and fatal hip fractures. A Norwegian prospective study of 63,000 women. J Epidemiol Community Health 1998;52(10):645–50.CrossRefPubMedCentralPubMed
8.
go back to reference Chen Z, Kooperberg C, Pettinger MB, Bassford T, Cauley JA, LaCroix AZ, et al. Validity of self-report for fractures among a multiethnic cohort of postmenopausal women: results from the Women’s Health Initiative observational study and clinical trials. Menopause 2004;11(3):264–74.CrossRefPubMed Chen Z, Kooperberg C, Pettinger MB, Bassford T, Cauley JA, LaCroix AZ, et al. Validity of self-report for fractures among a multiethnic cohort of postmenopausal women: results from the Women’s Health Initiative observational study and clinical trials. Menopause 2004;11(3):264–74.CrossRefPubMed
9.
go back to reference National Osteoporosis Foundation. Clinician’s Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Foundation 2014. National Osteoporosis Foundation. Clinician’s Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Foundation 2014.
Metadata
Title
Predicting Fracture Risk in Younger Postmenopausal Women: Comparison of the Garvan and FRAX Risk Calculators in the Women’s Health Initiative Study
Authors
Carolyn J. Crandall, MD, MS
Joseph Larson, MS
Andrea LaCroix, PhD
Jane A. Cauley, DrPH
Meryl S. LeBoff, MD
Wenjun Li, PhD
Erin S. LeBlanc, MD, MPH
Beatrice J. Edwards, MD, MPH
JoAnn E. Manson, MD, DrPH
Kristine Ensrud, MD, MPH
Publication date
01-02-2019
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 2/2019
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-018-4696-z

Other articles of this Issue 2/2019

Journal of General Internal Medicine 2/2019 Go to the issue